MedTrace Logo

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

NCT06298643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2025-12-04

No results posted yet for this study

Summary

The purpose of this study is to describe the treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs of lower-risk myelodysplastic syndromes patients in Japan.

Conditions

  • Lower-risk Myelodysplastic Syndromes

Interventions

PROCEDURE

Red blood cell transfusion

≥2 units of red blood cell transfusion

PROCEDURE

Red blood cell transfusion

0 units or \<2 units of red blood cell transfusion

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-22
Primary Completion
2025-07-09
Completion
2025-07-09
FDA Drug
Yes

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06298643 on ClinicalTrials.gov